Granting Stock Options to Directors
First written in FY2017-Q3. 17 of 18 entries say "Advanced", first in FY2017. Latest entry: FY2027-H1.
- FY2027-H1AdvancedAnnual report
「Resolution date 16 April 2026 Categories and number of persons eligible for grants (people) Directors of the Company, excluding outside directors and part-time directors 4 Number of stock acquisition rights (rights)* 78 Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 7,800 Exercise period for the stock acquisition rights* From 1 July 2026 to 30 June 2041」
Stock acquisition rights equivalent to 7,800 common shares were granted to 4 directors, excluding outside directors and part-time directors. - FY2026-H1AdvancedAnnual report
「Resolution date 21 April 2025 Category and number of eligible persons (people) Directors of the company excluding outside and part-time directors, 6 Number of share acquisition rights (units)* 81 Class, description and number of shares underlying the share acquisition rights (shares)* Common shares, 8,100 Exercise period for the share acquisition rights* 2 July 2025 to 1 July 2040」
For the grant resolved on 21 April 2025 and issued on 2 June, the company granted stock options equivalent to 8,100 common shares to 6 directors, with an exercise period through 1 July 2040. - FY2025AdvancedAnnual report
「17th Stock Option Directors of the company 7 Common shares 5,000 Exercise period 22 August 2024 to 21 August 2039」
The company disclosed the grant of 5,000 shares under the 17th stock option plan to 7 directors and the exercise of 4,300 shares during the fiscal year. - FY2024AdvancedAnnual report
「Under the 16th stock option plan, the company granted 9,400 common shares to 6 directors, with an exercise period from 21 August 2023 to 20 August 2038.」
The company granted 9,400 shares under the 16th stock option plan to 6 directors, and 6,800 shares were exercised during the fiscal year. - FY2024-Q2AdvancedAnnual report
「Resolution date 31 May 2023 Category and number of eligible persons (people) Full-time directors of the company, 6 Number of share acquisition rights (units)* 94 Class, description and number of shares underlying the share acquisition rights (shares)* Common shares, 9,400 Exercise period for the share acquisition rights* 21 August 2023 to 20 August 2038」
The company granted stock options equivalent to 9,400 common shares to 6 full-time directors, with an exercise period through 20 August 2038. - FY2023-Q2AdvancedAnnual report
「Resolution date: 31 May 2022 Category and number of eligible persons (people): Full-time directors of the company, 6 Number of share acquisition rights (units): 127 Class, description and number of shares underlying the share acquisition rights (shares): Common shares, 12,700 Exercise period for the share acquisition rights: 21 August 2022 to 20 August 2037」
The company granted stock options equivalent to 12,700 common shares to 6 full-time directors, with an exercise period through 20 August 2037. - FY2022AdvancedAnnual report
「13th Stock Option Directors of the company 6 Common shares 12,800 shares Exercise period 21 August 2020 to 20 August 2035」
The company disclosed the grant of the 13th stock options for 12,800 shares to 6 directors and the decrease of treasury shares by 7,100 shares due to exercises during the fiscal year. - FY2021-Q2AdvancedAnnual report
「Resolution date: 27 May 2020 Category and number of eligible persons (people): Directors of the company, 6 Class, description and number of shares underlying the share acquisition rights (shares): Common shares, 12,800 Exercise period for the share acquisition rights: 21 August 2020 to 20 August 2035」
The company newly granted stock options equivalent to 12,800 common shares to 6 directors, with an exercise period from 21 August 2020 to 20 August 2035. - FY2020AdvancedAnnual report
「Under the 12th stock option plan, the company granted 15,000 common shares to 7 directors, with an exercise period from 21 August 2019 to 20 August 2034.」
The company granted 15,000 shares under the 12th stock option plan to 7 directors, and 9,600 shares were exercised during the fiscal year. - FY2020-Q3AdvancedAnnual report
「Resolution date 25 June 2019 Category and number of eligible persons (people) Directors of the company, 7 Number of share acquisition rights (units)* 150 Class, description and number of shares underlying the share acquisition rights (shares)* Common shares 15,000 Exercise period for the share acquisition rights* 21 August 2019 to 20 August 2034」
For the issuance dated 21 July 2019, the company granted stock options equivalent to 15,000 common shares to 7 directors, with an exercise period through 20 August 2034. - FY2019-Q3AdvancedAnnual report
「11th Stock Option Category and number of eligible persons Directors of the company, 7 Number of stock options by class of shares (Note) Common shares, 16,300 Grant date 21 July 2018 Exercise period 21 August 2018 to 20 August 2033」
The company granted 16,300 common-share stock options under the 11th stock option plan to 7 directors, with an exercise period from 21 August 2018 to 20 August 2033. - FY2018AdvancedAnnual report
「After vesting (shares): Balance at the end of the previous consolidated fiscal year, 10,800; vested, 18,100; exercised, 8,200; unexercised balance, 9,900」
Under the 10th stock option plan, 18,100 shares were granted to 8 directors, 8,200 were exercised, and the unexercised balance at period-end was 9,900 shares. - FY2018-Q3AdvancedAnnual report
「10th Stock Option Category and number of eligible persons: Directors of the company, 8 Number of stock options by class of shares (Note): Common shares, 18,100 Grant date: 21 July 2017 Exercise period: 21 August 2017 to 20 August 2032」
The company granted 18,100 common-share stock options under the 10th stock option plan to 8 directors, with an exercise period from 21 August 2017 to 20 August 2032. - FY2017AdvancedAnnual report
「For the 9th stock options, 4,500 shares were exercised and 10,800 remained unexercised.」
Of the 15,300 shares granted under the 9th stock options for directors, 4,500 were exercised and 10,800 remained unexercised. - FY2017-Q3First statedAnnual report
「9th Stock Option Category and number of eligible persons: Directors of the company, 9 Number of stock options by class of shares (Note): Common shares, 15,300 Grant date: 21 July 2016 Exercise period: 21 August 2016 to 20 August 2031」
The company granted stock options for 15,300 common shares to 9 directors, with an exercise period from 21 August 2016 to 20 August 2031.